文献速递关节外科

机器人辅助全髋关节置换术与降低全因翻修或脱位翻修风险相关吗?基于美国关节置换登记系统的分析

Is Robotic-assisted THA Associated With Decreased Risk of All-cause Revision or Revision for Dislocation? An Analysis of the American Joint Replacement Registry.
PubMed 文献 · Clin Orthop Relat Res · 2026-06-03

该回顾性比较研究利用美国关节置换登记系统(AJRR)及其Medicare理赔数据链接,纳入2017至2021年接受初次择期THA的65岁及以上患者,比较机器人辅助THA(n=10,988)与常规THA(n=113,477)在至少2年随访时的翻修风险。经混杂变量调整后,机器人辅助THA与常规THA的全因翻修风险无差异(1.9% vs 2.1%,HR 0.9 [95%CI 0.7-1.1],p=0.42),但脱位翻修风险较低(0.3% vs 0.6%,HR 0.5 [95%CI 0.3-0.9],p=0.03)。

要点

  • 机器人辅助THA与常规THA的2年全因翻修风险无显著差异。
  • 机器人辅助THA的2年脱位翻修风险低于常规THA(HR 0.5)。
  • 在早期脱位风险值得关注的情况下可考虑机器人辅助THA。

核心结论

  • 机器人辅助THA在2年时全因翻修风险与常规THA无差异,但与较低的脱位翻修风险相关。

研究设计与样本

  • 回顾性比较研究,使用美国关节置换登记系统(AJRR)及其Medicare理赔数据链接,纳入2017至2021年接受初次择期THA的65岁及以上患者,机器人辅助THA组n=10,988,常规THA组n=113,477。

主要发现

  • 调整混杂变量后,2年全因翻修率机器人辅助THA为1.9%(208/10,988),常规THA为2.1%(2357/113,477),HR 0.9(95%CI 0.7-1.1),p=0.42。
  • 脱位翻修率机器人辅助THA为0.3%(35/10,988),常规THA为0.6%(689/113,477),HR 0.5(95%CI 0.3-0.9),p=0.03。

关键数值与推荐

  • 采用混合效应Cox回归模型,纳入年龄、Charlson合并症指数(CCI)、住院时间(LOS)、性别、麻醉类型和种族,术者和机构作为随机效应。
  • 两组的平均年龄均为74±6岁(p=0.15),女性比例均为60%(常规THA 67,903/113,447 vs 机器人辅助THA 6,540/10,988;p=0.51)。

临床怎么用

  • 在早期脱位风险值得关注的临床场景中,可考虑将机器人辅助THA作为降低该风险的手段。
  • 在机器人辅助THA显示出明确的免翻修植入物生存获益之前,术者应对该技术的广泛采用保持谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robot-assisted THA is becoming more common, and evidence suggests that robot assistance improves the accuracy of acetabular cup positioning. By means of reducing implant malpositioning, robot-assisted THA has been proposed as a method to reduce the risk of revision surgery and particularly revision due to dislocation. However, this has not yet been explored using an arthroplasty registry. QUESTIONS/PURPOSES: (1) In a dataset drawn from the American Joint Replacement Registry (AJRR) and its Medicare claims data linkage, after controlling for confounding variables, is robot-assisted THA associated with a decreased risk of all-cause revision at minimum 2-year follow-up? (2) After controlling for confounding variables, is robot-assisted THA associated with a decreased risk of revision for dislocation at minimum 2-year follow-up? METHODS: The AJRR and its Medicare claims data linkage were used to create a retrospective comparative study of patients aged 65 years or older who underwent primary elective robot-assisted THA (n = 10,988) or conventional THA (n = 113,477) between 2017 and 2021. All patients within the AJRR who had undergone primary THA and had complete records with respect to robot data were included. The AJRR was selected for this study because of its Medicare linkage, and therefore follow-up data are considered near complete. Both cohorts had the same mean age (74 ± 6 years; p = 0.15) and the same proportion of females (60% [67,903 of 113,447] for conventional THA versus 60% [6540 of 10,988] for robot-assisted THA; p = 0.51). Mixed-effect Cox regression models were used to determine the hazard of all-cause revision and revision for dislocation at 2 years. Variables included within these models were age, Charlson comorbidity index (CCI), length of stay (LOS), sex, anesthesia type, and race. Surgeon and institution were controlled as the random effect within these models. RESULTS: After controlling for confounding variables, the risk of all-cause revision at 2 years did not differ between robot-assisted THA and conventional THA (1.9% [208 of 10,988] versus 2.1% [2357 of 113,477], HR 0.9 [95% confidence interval (CI) 0.7 to 1.1]; p = 0.42). Revision for dislocation was lower in robot-assisted THA (0.3% [35 of 10,988]) compared to conventional THA (0.6% (689 of 113,477), HR 0.5 [95% CI 0.3 to 0.9]; p = 0.03). CONCLUSION: Robot-assisted THA did not demonstrate a difference in all-cause revision at 2 years, but robot-assisted THA was associated with a reduced risk of revision for dislocation compared to conventional THA. This study demonstrates that robotic assistance is a potentially useful adjunct during THA to decrease the risk of early revision for dislocation. In clinical scenarios where early dislocation might be a concern, robot-assisted THA might be considered a means to mitigate this risk. However, until or unless robot assistance demonstrates clear improvement regarding revision-free implant survival, surgeons should remain cautious of widespread adoption of this technology. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Kirchner GJ, Riley C, Jimenez E, et al. Is Robotic-assisted THA Associated With Decreased Risk of All-cause Revision or Revision for Dislocation? An Analysis of the American Joint Replacement Registry. Clin Orthop Relat Res. 2026. PMID: 42233625. doi:10.1097/CORR.0000000000004011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。